The expression of the ribonucleotide reductase M1 (RRM1) gene may be associated with the efficacy of HU treatment in some cancers, and some researchers have suggested that overexpression of the RRM1 gene might confer resistance to HU [21]. This evidence concerns the gene RRM1 and cancer.